(S)-tert-Butyl (1-amino-3-methyl-1-oxobutan-2-yl)carbamate

Catalog No. :
ACNXDS741
CAS No. :
35150-08-4
Molecular Formula :
C10H20N2O3
Molecular Weight :
216.28

IUPAC Name:tert-butyl (S)-(1-amino-3-methyl-1-oxobutan-2-yl)carbamate

(S)-tert-Butyl (1-amino-3-methyl-1-oxobutan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$69.00Login to see priceIn stockIn stock
100g97%$234.00Login to see priceIn stockIn stock
500g97%$852.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl (1-amino-3-methyl-1-oxobutan-2-yl)carbamate
IUPAC Nametert-butyl (S)-(1-amino-3-methyl-1-oxobutan-2-yl)carbamate
MDL No.MFCD00190841
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESO=C(OC(C)(C)C)N[C@@H](C(C)C)C(N)=O
InChI KeyNZSZYROZOXUFSG-ZETCQYMHSA-N
SynonymBoc-L-valine amide | SCHEMBL8210446 | tert-Butyl (S)-(1-amino-3-methyl-1-oxobutan-2-yl)carbamate | NZSZYROZOXUFSG-ZETCQYMHSA-N | AM82375 | (S)-tert-Butyl 1-amino-3-methyl-1-oxobutan-2-ylcarbamate | (S)-tert-Butyl(1-amino-3-methyl-1-oxobutan-2-yl)carbamate
CAS No.35150-08-4
PubChem CID11241393

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACNXDS741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNXDS741 route product structure diagram
    ACNXDS74135150-08-4 In Stock
Inquiry

2. ACNXDS741 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACNXDS741 route product structure diagram
    ACNXDS74135150-08-4 In Stock
Inquiry

Comments (0)